Theravance Biopharma, Inc. Ordinary Shares (NASDAQ: TBPH) last traded at $17.01, up 0.35% on the session. The quote above updates while this page is open; the figures below are drawn from Theravance Biopharma, Inc. Ordinary Shares’s own filings and are restated only when a new one is published.
Theravance Biopharma, Inc. Ordinary Shares trades on NASDAQ under the ticker TBPH. Its market capitalisation is $883.14 million.
Valuation measures for Theravance Biopharma, Inc. Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $883.14M |
|---|---|
| P/E ratio | 16.84 |
| Price / sales | 8.47 |
| Price / book | 3.05 |
| Beta | 0.54 |
Trailing-twelve-month figures tagged in Theravance Biopharma, Inc. Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $104.31M |
|---|---|
| Net income (TTM) | $53.81M |
| EPS (TTM) | $1.01 |
| Operating margin | -4.03% |
| Return on equity | 18.57% |
| Cash | $219.77M |
Range and volume for TBPH over the past 52 weeks.
| 52-week high | $21.03 |
|---|---|
| 52-week low | $13.08 |
| Volume | 716.3K |
| Average volume | 642.7K |
| Previous close | $16.95 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.